KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Invested Capital (2017 - 2025)

Historic Invested Capital for Twist Bioscience (TWST) over the last 9 years, with Q4 2025 value amounting to $456.1 million.

  • Twist Bioscience's Invested Capital rose 3.38% to $456.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $456.1 million, marking a year-over-year increase of 3.38%. This contributed to the annual value of $473.0 million for FY2025, which is 5.69% up from last year.
  • Twist Bioscience's Invested Capital amounted to $456.1 million in Q4 2025, which was up 3.38% from $473.0 million recorded in Q3 2025.
  • In the past 5 years, Twist Bioscience's Invested Capital ranged from a high of $863.4 million in Q1 2022 and a low of $440.1 million during Q1 2025
  • Over the past 5 years, Twist Bioscience's median Invested Capital value was $601.4 million (recorded in 2021), while the average stood at $603.5 million.
  • As far as peak fluctuations go, Twist Bioscience's Invested Capital soared by 13075.45% in 2021, and later crashed by 2530.77% in 2024.
  • Over the past 5 years, Twist Bioscience's Invested Capital (Quarter) stood at $635.3 million in 2021, then rose by 17.48% to $746.3 million in 2022, then decreased by 20.94% to $590.0 million in 2023, then decreased by 22.73% to $455.9 million in 2024, then rose by 0.03% to $456.1 million in 2025.
  • Its Invested Capital was $456.1 million in Q4 2025, compared to $473.0 million in Q3 2025 and $478.2 million in Q2 2025.